Inicio>>Signaling Pathways>> Immunology/Inflammation>> STING>>diABZI STING agonist-1 Tautomerism

diABZI STING agonist-1 Tautomerism

Catalog No.GC35854

El tautomerismo diABZI STING agonist-1 (compuesto 3) es un agonista del receptor del estimulador selectivo de genes de interferón (STING), con CE50 de 130, 186 nM para humanos y ratones, respectivamente.

Products are for research use only. Not for human use. We do not sell to patients.

diABZI STING agonist-1 Tautomerism Chemical Structure

Cas No.: 2138498-18-5

Tamaño Precio Disponibilidad Cantidad
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with an EC50s of 130 for human PBMCs. EC50: 130 nM (human STNG in PBMCs) [1].

diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with an EC50s of 130 for human PBMCs.

diABZI STING agonist-1 (Tautomerism) is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. At a concentration of 1 μM, diABZI STING agonist-1 (compound 3) demonstrates high selectivity against more than 350 kinases tested[1].

[1]. Ramanjulu JM, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018 Nov 7.

Reseñas

Review for diABZI STING agonist-1 Tautomerism

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for diABZI STING agonist-1 Tautomerism

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.